ÂÜÀòÂÒÂ×

Dr. Walling brings extensive experience in global clinical development of oncology and rare disease drugs, most recently serving as chief medical officer for Plexxikon. She was previously vice president, clinical development at BioMarin Pharmaceutical. She received her PhD in biology from the University of Southampton, UK and her MBChB from the University of Bristol.